These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29226809)

  • 21. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.
    Zhu MH; Liu ZJ; Hu QY; Yang JY; Jin Y; Zhu N; Huang Y; Shi DH; Liu MJ; Tan HY; Zhao L; Lv QY; Yi ZH; Wu FC; Li ZZ
    Mil Med Res; 2022 Oct; 9(1):59. PubMed ID: 36253804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.
    Ball MP; Warren KR; Feldman S; McMahon RP; Kelly DL; Buchanan RW
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):17-25. PubMed ID: 21459735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia.
    Henderson DC; Kunkel L; Nguyen DD; Borba CP; Daley TB; Louie PM; Freudenreich O; Cather C; Evins AE; Goff DC
    Acta Psychiatr Scand; 2006 Feb; 113(2):142-7. PubMed ID: 16423166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
    Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    Weiser M; Levi L; Burshtein S; Hagin M; Matei VP; Podea D; Micluția I; Tiugan A; Păcală B; Grecu IG; Noy A; Zamora D; Davis JM
    J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
    Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
    Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group.
    Tollefson GD; Dellva MA; Mattler CA; Kane JM; Wirshing DA; Kinon BJ
    J Clin Psychopharmacol; 1999 Oct; 19(5):435-43. PubMed ID: 10505585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Vitamin D Supplementation on Outcomes in People With Early Psychosis: The DFEND Randomized Clinical Trial.
    Gaughran F; Stringer D; Wojewodka G; Landau S; Smith S; Gardner-Sood P; Taylor D; Jordan H; Whiskey E; Krivoy A; Ciufolini S; Stubbs B; Casetta C; Williams J; Moore S; Allen L; Rathod S; Boardman A; Khalifa R; Firdosi M; McGuire P; Berk M; McGrath J
    JAMA Netw Open; 2021 Dec; 4(12):e2140858. PubMed ID: 34962559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of pimozide augmentation for clozapine partial responders with schizophrenia.
    Gunduz-Bruce H; Oliver S; Gueorguieva R; Forselius-Bielen K; D'Souza DC; Zimolo Z; Tek C; Kaliora S; Ray S; Petrides G
    Schizophr Res; 2013 Feb; 143(2-3):344-7. PubMed ID: 23219861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
    Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY
    J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.
    Risch SC; Horner MD; McGurk SR; Palecko S; Markowitz JS; Nahas Z; DeVane CL
    Schizophr Res; 2007 Jul; 93(1-3):131-5. PubMed ID: 17391930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients.
    Ghaderi A; Banafshe HR; Mirhosseini N; Moradi M; Karimi MA; Mehrzad F; Bahmani F; Asemi Z
    BMC Psychiatry; 2019 Feb; 19(1):77. PubMed ID: 30791895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Open-label pilot study on vitamin D₃ supplementation for antipsychotic-associated metabolic anomalies.
    Thakurathi N; Stock S; Oppenheim CE; Borba CP; Vincenzi B; Seidman LJ; Stone WS; Henderson DC
    Int Clin Psychopharmacol; 2013 Sep; 28(5):275-82. PubMed ID: 23694999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.
    Bugarski-Kirola D; Iwata N; Sameljak S; Reid C; Blaettler T; Millar L; Marques TR; Garibaldi G; Kapur S
    Lancet Psychiatry; 2016 Dec; 3(12):1115-1128. PubMed ID: 27816567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
    Barnes TR; Leeson VC; Paton C; Marston L; Davies L; Whittaker W; Osborn D; Kumar R; Keown P; Zafar R; Iqbal K; Singh V; Fridrich P; Fitzgerald Z; Bagalkote H; Haddad PM; Husni M; Amos T
    Health Technol Assess; 2017 Sep; 21(49):1-56. PubMed ID: 28869006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
    J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial.
    Salekzamani S; Bavil AS; Mehralizadeh H; Jafarabadi MA; Ghezel A; Gargari BP
    Endocrine; 2017 Jul; 57(1):51-59. PubMed ID: 28509078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.